Prices delayed by at least 15 minutes | Print

Live UK pricing:

Kanabo Group PLC (KNB)

ORD 2.5P
Sell: 0.20p|Buy: 0.25p|Change: 0.07 (-25.00%)

Open 

0.30p


Previous close 

0.30p


Trade high 

0.33p


Volume 

11,421


Year high 

1.10p


Year low 

0.15p


Dividend yield 

–


Market capitalisation 

£1.42 mn


P/E ratio 

0.03


ISIN 

GB00BYQCS703


Share price

Performance 13/11/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Kanabo Group PLC 0.00
More...

Company profile

Kanabo Group PLC is a digital health company committed to transforming patient care through its technology platform and specialized treatment offerings. It is focused on researching, developing, and commercializing regulated medicinal cannabis-derived formulations and therapeutic inhalation devices. Its NHS-approved online telehealth platform, The GP Service, which provides patients with video consultations, online prescriptions, and primary care services. Its segments include Primary Care, which includes telepharma services provided by GPS, and Secondary Care, which includes the development and distribution of cannabis derived medicinal and wellness products. It derives the majority of revenue from Primary Care. Geographically, it operates in the United Kingdom and Israel.

Sector 

Healthcare


News

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.